See the original post here:
Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh